S
PCRX icon

SignatureFD’s Pacira BioSciences PCRX Stock Holding History

SignatureFD’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.1K Buy
201
+74
+58% +$1.75K ﹤0.01% 2857
2026
Q1 		$2.87K Sell
127
-20
-14% -$444 ﹤0.01% 2954
2025
Q4 		$3.8K Hold
147
– – ﹤0.01% 2786
2025
Q3 		$3.79K Buy
147
+6
+4% +$147 ﹤0.01% 2770
2025
Q2 		$3.37K Hold
141
– – ﹤0.01% 2720
2025
Q1 		$3.5K Hold
141
– – ﹤0.01% 2716
2024
Q4 		$2.66K Buy
141
+56
+66% +$983 ﹤0.01% 2784
2024
Q3 		$1.28K Sell
85
-12
-12% -$205 ﹤0.01% 2949
2024
Q2 		$2.77K Sell
97
-257
-73% -$7.32K ﹤0.01% 2673
2024
Q1 		$10.3K Buy
354
+7
+2% +$215 ﹤0.01% 2284
2023
Q4 		$11.7K Buy
347
+313
+921% +$9.16K ﹤0.01% 2191
2023
Q3 		$1.04K Sell
34
-20
-37% -$721 ﹤0.01% 2931
2023
Q2 		$2.16K Sell
54
-450
-89% -$18.6K ﹤0.01% 2781
2023
Q1 		$20.6K Buy
504
+439
+675% +$17.5K ﹤0.01% 1856
2022
Q4 		$2.51K Sell
65
-17
-21% -$827 ﹤0.01% 2728
2022
Q3 		$4K Buy
82
+18
+28% +$1K ﹤0.01% 2549
2022
Q2 		$4K Buy
64
+33
+106% +$2.16K ﹤0.01% 2532
2022
Q1 		$2K Hold
31
– – ﹤0.01% 2837
2021
Q4 		$2K Hold
31
– – ﹤0.01% 2768
2021
Q3 		$2K Hold
31
– – ﹤0.01% 2688
2021
Q2 		$2K Hold
31
– – ﹤0.01% 2606
2021
Q1 		$2K Hold
31
– – ﹤0.01% 2510
2020
Q4 		$2K Sell
31
-8
-21% -$468 ﹤0.01% 2293
2020
Q3 		$2K Buy
39
+8
+26% +$465 ﹤0.01% 2259
2020
Q2 		$2K Buy
+31
New +$1.3K ﹤0.01% 2164

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SignatureFD's PCRX Position: Q2 2026 in Review

SignatureFD increased its Pacira BioSciences (PCRX) stake by 58% in Q2 2026, buying an estimated $1.75K and bringing the position to 201 shares worth $5.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2857.

SignatureFD first reported a position in PCRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $20.6K in Q1 2023. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • SignatureFD held 201 shares of Pacira BioSciences worth $5.1K as of Q2 2026.
  • SignatureFD bought 74 Pacira BioSciences shares in Q2 2026, an estimated $1.75K.
  • Pacira BioSciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2857 holding.
  • SignatureFD first reported a position in Pacira BioSciences in Q2 2020 and has held it in 25 quarters since.
  • SignatureFD's Pacira BioSciences position peaked at $20.6K in Q1 2023.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.